Combining these data with the results from Cohort II, we determined that high Lin28B expression was correlated with poor prognosis and was an independent prognosticator of overall survival among breast cancer patients for all three breast cancer subtypes (Fig. 1h and Supplementary Tables 3–5), hinting at Lin28B’s important role in tumor progression. The gene discussed is LIN28B; the disease is neoplasm.